Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00032084 · ClinicalTrials.gov registry record · Phase 3
S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery
A Phase 3 study, sponsored by SWOG Cancer Research Network.
- Terminated
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
NCT00032084 is a Phase 3 study that was terminated before completion, run by SWOG Cancer Research Network. The registered enrollment target is 10 participants.
The verdict
NCT00032084, a Phase 3 study, was terminated before completion, sponsored by SWOG Cancer Research Network.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
Study Summary
RATIONALE: A program that includes bupropion may be more effective in helping early-stage lung cancer patients to quit smoking. It is not yet known if a program to quit smoking is more effective with or without bupropion. PURPOSE: Randomized phase III trial to determine the effectiveness of a program to quit smoking with or without bupropion in treating patients who have undergone surgery for stage I or stage II non-small cell lung cancer.
Interventions
- PROCEDURE psychosocial assessment and care
- DRUG bupropion hydrochloride
- DRUG nicotine
- BEHAVIORAL smoking cessation intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2002-01 |
| Est. Completion | 2004-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00032084
The ClinicalTrials.gov registry entry for NCT00032084 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which psychosocial assessment and care is the first listed.
NCT00032084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00032084 about?
NCT00032084 is a clinical study titled "S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery". RATIONALE: A program that includes bupropion may be more effective in helping early-stage lung cancer patients to quit smoking. It is not yet known if a program to quit smoking is more effective with or without bupropion. PURPOSE: Randomized phase III trial to determine the effectiveness of a progr...
What is the current status of trial NCT00032084?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2002-01. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00032084?
The interventions under investigation include: psychosocial assessment and care (PROCEDURE), bupropion hydrochloride (DRUG), nicotine (DRUG), smoking cessation intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00032084?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.